Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
ASKA Pharmaceutical Holdings Co Ltd
TSE:4886
ASKA Pharmaceutical Holdings Co Ltd
TSE:4886
Price:
2 051
JPY
-0.24%
Market Closed
Market Cap:
¥59B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
ASKA Pharmaceutical Holdings Co Ltd
TSE:4886
|
JP |
|
Talon Metals Corp
TSX:TLO
|
VG |
|
I
|
Inter Globe Finance Ltd
BSE:511391
|
IN |
|
FG Nexus Inc
F:LU5
|
US |
|
H
|
H & R Block Inc
XMUN:HRB
|
US |
|
Croda International PLC
LSE:CRDA
|
UK |
|
Havilah Resources Ltd
ASX:HAV
|
AU |
|
L
|
Leform Bhd
KLSE:LEFORM
|
MY |
|
Almirall SA
F:E2Z
|
ES |
|
Solocal Group SE
F:QS30
|
FR |
|
W
|
WhiteHorse Finance Inc
F:M9X
|
US |
|
A
|
Anapass Inc
KOSDAQ:123860
|
KR |
|
U
|
Upbound Group Inc
F:RAC
|
US |
|
Kingfisher PLC
LSE:KGF
|
UK |
|
Mitsubishi HC Capital Inc
F:5B4
|
JP |
|
N
|
Noah Holdings Ltd
HKEX:6686
|
CN |
|
Lundin Mining Corp
TSX:LUN
|
CA |
|
G
|
Gap Inc
LSE:0ITS
|
US |
Wall St Price Targets
Price Forecast
Based on 3 analysts
Based on 3 analysts
+19% Upside
from
¥2 051
today
ASKA Pharmaceutical Holdings Co Ltd (4886)’s 12-month stock price forecast through October 2027 has a consensus target of ¥2 448, implying 19% upside. The forecast is based on price targets from 3 Wall Street analysts.
Analyst Rating
No ratings yet
No ratings yet
ASKA Pharmaceutical Holdings Co Ltd Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ASKA Pharmaceutical Holdings Co Ltd's stock price target?
Price Target
2 448
JPY
2 448
JPY
According to Wall Street analysts, the average 1-year price target for ASKA Pharmaceutical Holdings Co Ltd is 2 448 JPY with a low forecast of 2 424 JPY and a high forecast of 2 520 JPY.
What is the Revenue forecast for ASKA Pharmaceutical Holdings Co Ltd?
Projected CAGR
4%
4%
Over the last 9 years, the compound annual growth rate for Revenue has been 4%. The projected CAGR for the next 3 years is 4%.
What is the Gross Profit forecast for ASKA Pharmaceutical Holdings Co Ltd?
Projected CAGR
6%
6%
Over the last 9 years, the compound annual growth rate for Gross Profit has been 7%. The projected CAGR for the next -2 years is 6%.
What is the Pre-Tax Income forecast for ASKA Pharmaceutical Holdings Co Ltd?
Projected CAGR
7%
7%
Over the last 9 years, the compound annual growth rate for Pre-Tax Income has been 9%. The projected CAGR for the next 3 years is 7%.
What is the Net Income forecast for ASKA Pharmaceutical Holdings Co Ltd?
Projected CAGR
6%
6%
Over the last 9 years, the compound annual growth rate for Net Income has been 7%. The projected CAGR for the next 3 years is 6%.